Suppr超能文献

质量源于设计(QbD)方法以匹配片剂光泽度。

Quality by design (QbD) approach to match tablet glossiness.

机构信息

Formulation Development, Piramal Pharma Solutions, Ahmedabad, India.

Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA.

出版信息

Pharm Dev Technol. 2020 Oct;25(8):1010-1017. doi: 10.1080/10837450.2020.1772291. Epub 2020 Jun 12.

Abstract

A quality by design (QbD) approach was used for a polyvinyl alcohol (PVA)-based coating to develop a 'look-alike' placebo tablet, which can match the glossiness (shine) of an innovator tablet. Critical coating parameters such as exhaust temperature, drying capacity, solid concentration in coating dispersion, and plasticizer concentration were studied using a full factorial design of experiment DoE). Total of 20 experimental coating runs was executed on a pilot scale using a perforated pan coater. Coated tablets were evaluated visually against the innovator product by a panel of 13 volunteers using an individual questionnaire about the tablet appearance. The tablet appearance included factors such as tablet surface shine, surface roughness, and logo bridging. These data were analyzed using JMP software. Solid concentration in coating dispersion and drying capacity were found to be the key contributing parameters for tablet surface shine. Human observations were more discerning in spotting subtle differences in tablet appearance than Munsell evaluation. By the judicious selection of a solid concentration in coating dispersion and drying conditions, a look-alike placebo tablet was successfully developed. Change in tablet shape or size did not affect the tablet shine. However, replacement of PVA-based coating with hydroxypropyl methylcellulose (HPMC)-based coating resulted in reduced shine irrespective of tablet shape and size.

摘要

采用质量源于设计(QbD)方法,开发了一种基于聚乙烯醇(PVA)的涂层,以制备一种“外观相似”的安慰剂片剂,使其光泽度(光泽)与创新药物片剂相匹配。使用全因子实验设计(DoE)研究了关键的涂层参数,如排气温度、干燥能力、涂层分散体中的固体浓度和增塑剂浓度。在中试规模上,使用多孔盘式涂布机共执行了 20 次实验性涂层运行。通过一个由 13 名志愿者组成的小组,使用关于片剂外观的个人问卷,对涂层片剂进行视觉评估,与创新产品进行对比。片剂外观包括片剂表面光泽度、表面粗糙度和标识桥接等因素。使用 JMP 软件分析这些数据。发现涂层分散体中的固体浓度和干燥能力是影响片剂表面光泽度的关键因素。与 Munsell 评估相比,人类观察在发现片剂外观的细微差异方面更加敏锐。通过明智地选择涂层分散体中的固体浓度和干燥条件,可以成功开发出外观相似的安慰剂片剂。片剂形状或尺寸的变化不会影响片剂的光泽度。然而,无论片剂形状和尺寸如何,用羟丙基甲基纤维素(HPMC)基涂层代替 PVA 基涂层都会导致光泽度降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验